Rapid Immunoconcentration Assay for detection of Antibodies to HIV 1 & 2 and HCV in Human Serum/Plasma ;
- UID
- MFG/IVD/2021/000113_f59a096232ffaf56e2ea5c61191ee0be_8e9984280e9a66575605391bd21ee39b
- Device class
- Class D
- Brand name
- Device
- Approving authority
- Sub Zonal Goa
- Product information
- Combiquic (Device) is used for the simultaneous and differential detection of antibodies specific to HIV 1 & 2 and HCV in human serum, plasma
Rapid Immunoconcentration Assay for detection of Antibodies to HIV 1 & 2 and HCV in Human Serum/Plasma ; is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000113_f59a096232ffaf56e2ea5c61191ee0be_8e9984280e9a66575605391bd21ee39b. This device is marketed under the brand name Device. The license holder is QUALPRO DIAGNOSTICS A DIVISION OF TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.